The question we get most.
“When will OCTAVE ship the injectable peptide line?” We get a version of this email about once a week. The answer, calmly, is: never.
Why never
Injectable peptides are pharmaceutical molecules. Selling them in Europe without a marketing authorisation from the European Medicines Agency or a member-state regulator is a criminal offence under EU pharmaceutical legislation. The risk is not commercial; it is custodial.
More importantly, even if it were not criminal, it would not be the right thing to do. Injectables require a prescriber, a safe administration setting, and a return path for adverse events. None of those things can be reasonably built into a direct-to-consumer brand without compromising patient safety.
What we sell
OCTAVE sells topical cosmetic serums. The mechanism is signal peptides at the skin surface. The active dose is on the front of the bottle. The whole product can be applied with two fingertips.
What we will not do
- We will not sell vials of lyophilized peptide.
- We will not sell bacteriostatic water.
- We will not sell needles, syringes, or any reconstitution kit.
- We will not give measured dosing advice for injectable peptides.
- We will not refer people to gray-market peptide vendors.
If you really want injectables
There is a legitimate pathway: a prescriber with a license, a pharmacy with a license, and a substance with a marketing authorisation. Speak to your doctor. Be skeptical of any online “telehealth” service that does not name its prescribing physician.
What this says about the brand
OCTAVE has the technical capability to sell injectable-grade product. The decision not to is a brand choice. It is also a choice about who we want as customers — people who buy a serum, finish a bottle, and order another in eight weeks. That is the whole business.